CD276 and non-small cell lung carcinoma: Another study analyzed tissue samples from 105 patients with NSCLC, not only found that high expression of CD276 protein is associated with poor prognosis, but also that CD276 can participate in the progression of NSCLC by inducing monocytes to develop into anti-inflammatory cells [17].